Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPHY-SEIN: Antibiotic Prophylaxis in Lumpectomy for Breast Cancer
NCT07898943Phase 3Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 3 trial of cefazolin in surgical site infection (SSI), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07898943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07898943.